InMode Ltd.
INMD Healthcare Medical Devices
InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.
Follow INMD
InMode Ltd. (INMD) P/E ratio
As of 16 October 2026, InMode Ltd. (INMD) trades at a P/E ratio of 11.3×. Over the past ten years it has ranged from 5.5× (July 2025) to 53.6× (September 2021); the current reading is higher than 40% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 10.1× | 42.79% |
| FY2024 | 7.0× | (24.53%) |
| FY2023 | 9.3× | (48.10%) |
| FY2022 | 18.0× | (48.77%) |
| FY2021 | 35.1× | 50.87% |
| FY2020 | 23.3× | 22.83% |
| FY2019 | 18.9× | 77.79% |
| FY2018 | 10.7× | 0.00% |
| FY2017 | 10.7× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 11.7× | 17.99% |
| Mar 2026 | 9.9× | (1.48%) |
| Dec 2025 | 10.1× | 47.21% |
| Sep 2025 | 6.8× | 17.86% |
| 30 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PRCT PROCEPT BioRobotics Corporation compare | n/m |
| CTKB Cytek Biosciences, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| LMRI Lumexa Imaging Holdings, Inc. compare | n/m |
| SIBN SiBone compare | n/m |
| QDEL QuidelOrtho Corporation compare | n/m |
| INMD InMode Ltd. | 11.3× |
| VREX VAREX IMAGING compare | 34.7× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)